Global Sleeping Pills Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Sleeping Pills market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Sleeping Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Sleeping Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Sleeping Pills market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Sleeping Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Sleeping Pills market include Abbott Laboratories, Takeda Pharmaceutical, Sanofi, Hayao, Cayman Chemical, Aurobindo Pharma, Apotex, Ambitropin and Allegiant Health, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sleeping Pills, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sleeping Pills, also provides the sales of main regions and countries. Of the upcoming market potential for Sleeping Pills, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sleeping Pills sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sleeping Pills market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sleeping Pills sales, projected growth trends, production technology, application and end-user industry.

Sleeping Pills Segment by Company

Abbott Laboratories
Takeda Pharmaceutical
Sanofi
Hayao
Cayman Chemical
Aurobindo Pharma
Apotex
Ambitropin
Allegiant Health
Actellon Pharmaceuticals

Sleeping Pills Segment by Type

Adapin (doxepin)
Ativan (lorazepam)
Ramelteon (Rozerem)
Eszopiclone (Lunesta)
Zolpidem

Sleeping Pills Segment by Application

Hospital Pharmacy
Retail Pharmacy

Sleeping Pills Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Sleeping Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Sleeping Pills market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Sleeping Pills significant trends, drivers, influence factors in global and regions.
6. To analyze Sleeping Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeping Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sleeping Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeping Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sleeping Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sleeping Pills industry.
Chapter 3: Detailed analysis of Sleeping Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Sleeping Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Sleeping Pills in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Sleeping Pills Sales Value (2020-2031)
1.2.2 Global Sleeping Pills Sales Volume (2020-2031)
1.2.3 Global Sleeping Pills Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Sleeping Pills Market Dynamics
2.1 Sleeping Pills Industry Trends
2.2 Sleeping Pills Industry Drivers
2.3 Sleeping Pills Industry Opportunities and Challenges
2.4 Sleeping Pills Industry Restraints
3 Sleeping Pills Market by Company
3.1 Global Sleeping Pills Company Revenue Ranking in 2024
3.2 Global Sleeping Pills Revenue by Company (2020-2025)
3.3 Global Sleeping Pills Sales Volume by Company (2020-2025)
3.4 Global Sleeping Pills Average Price by Company (2020-2025)
3.5 Global Sleeping Pills Company Ranking (2023-2025)
3.6 Global Sleeping Pills Company Manufacturing Base and Headquarters
3.7 Global Sleeping Pills Company Product Type and Application
3.8 Global Sleeping Pills Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Sleeping Pills Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Sleeping Pills Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Sleeping Pills Market by Type
4.1 Sleeping Pills Type Introduction
4.1.1 Adapin (doxepin)
4.1.2 Ativan (lorazepam)
4.1.3 Ramelteon (Rozerem)
4.1.4 Eszopiclone (Lunesta)
4.1.5 Zolpidem
4.2 Global Sleeping Pills Sales Volume by Type
4.2.1 Global Sleeping Pills Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Sleeping Pills Sales Volume by Type (2020-2031)
4.2.3 Global Sleeping Pills Sales Volume Share by Type (2020-2031)
4.3 Global Sleeping Pills Sales Value by Type
4.3.1 Global Sleeping Pills Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Sleeping Pills Sales Value by Type (2020-2031)
4.3.3 Global Sleeping Pills Sales Value Share by Type (2020-2031)
5 Sleeping Pills Market by Application
5.1 Sleeping Pills Application Introduction
5.1.1 Hospital Pharmacy
5.1.2 Retail Pharmacy
5.2 Global Sleeping Pills Sales Volume by Application
5.2.1 Global Sleeping Pills Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Sleeping Pills Sales Volume by Application (2020-2031)
5.2.3 Global Sleeping Pills Sales Volume Share by Application (2020-2031)
5.3 Global Sleeping Pills Sales Value by Application
5.3.1 Global Sleeping Pills Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Sleeping Pills Sales Value by Application (2020-2031)
5.3.3 Global Sleeping Pills Sales Value Share by Application (2020-2031)
6 Sleeping Pills Regional Sales and Value Analysis
6.1 Global Sleeping Pills Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Sleeping Pills Sales by Region (2020-2031)
6.2.1 Global Sleeping Pills Sales by Region: 2020-2025
6.2.2 Global Sleeping Pills Sales by Region (2026-2031)
6.3 Global Sleeping Pills Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Sleeping Pills Sales Value by Region (2020-2031)
6.4.1 Global Sleeping Pills Sales Value by Region: 2020-2025
6.4.2 Global Sleeping Pills Sales Value by Region (2026-2031)
6.5 Global Sleeping Pills Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Sleeping Pills Sales Value (2020-2031)
6.6.2 North America Sleeping Pills Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Sleeping Pills Sales Value (2020-2031)
6.7.2 Europe Sleeping Pills Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Sleeping Pills Sales Value (2020-2031)
6.8.2 Asia-Pacific Sleeping Pills Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Sleeping Pills Sales Value (2020-2031)
6.9.2 South America Sleeping Pills Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Sleeping Pills Sales Value (2020-2031)
6.10.2 Middle East & Africa Sleeping Pills Sales Value Share by Country, 2024 VS 2031
7 Sleeping Pills Country-level Sales and Value Analysis
7.1 Global Sleeping Pills Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Sleeping Pills Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Sleeping Pills Sales by Country (2020-2031)
7.3.1 Global Sleeping Pills Sales by Country (2020-2025)
7.3.2 Global Sleeping Pills Sales by Country (2026-2031)
7.4 Global Sleeping Pills Sales Value by Country (2020-2031)
7.4.1 Global Sleeping Pills Sales Value by Country (2020-2025)
7.4.2 Global Sleeping Pills Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Sleeping Pills Sales Value Growth Rate (2020-2031)
7.5.2 USA Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Sleeping Pills Sales Value Growth Rate (2020-2031)
7.6.2 Canada Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Sleeping Pills Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Sleeping Pills Sales Value Growth Rate (2020-2031)
7.8.2 Germany Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Sleeping Pills Sales Value Growth Rate (2020-2031)
7.9.2 France Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.9.3 France Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Sleeping Pills Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Sleeping Pills Sales Value Growth Rate (2020-2031)
7.11.2 Italy Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Sleeping Pills Sales Value Growth Rate (2020-2031)
7.12.2 Spain Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Sleeping Pills Sales Value Growth Rate (2020-2031)
7.13.2 Russia Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Sleeping Pills Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Sleeping Pills Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Sleeping Pills Sales Value Growth Rate (2020-2031)
7.16.2 China Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.16.3 China Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Sleeping Pills Sales Value Growth Rate (2020-2031)
7.17.2 Japan Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Sleeping Pills Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Sleeping Pills Sales Value Growth Rate (2020-2031)
7.19.2 India Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.19.3 India Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Sleeping Pills Sales Value Growth Rate (2020-2031)
7.20.2 Australia Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Sleeping Pills Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Sleeping Pills Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Sleeping Pills Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Sleeping Pills Sales Value Growth Rate (2020-2031)
7.24.2 Chile Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Sleeping Pills Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Sleeping Pills Sales Value Growth Rate (2020-2031)
7.26.2 Peru Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Sleeping Pills Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Sleeping Pills Sales Value Growth Rate (2020-2031)
7.28.2 Israel Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Sleeping Pills Sales Value Growth Rate (2020-2031)
7.29.2 UAE Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Sleeping Pills Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Sleeping Pills Sales Value Growth Rate (2020-2031)
7.31.2 Iran Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Sleeping Pills Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Sleeping Pills Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Sleeping Pills Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Sleeping Pills Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Comapny Information
8.1.2 Abbott Laboratories Business Overview
8.1.3 Abbott Laboratories Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.1.4 Abbott Laboratories Sleeping Pills Product Portfolio
8.1.5 Abbott Laboratories Recent Developments
8.2 Takeda Pharmaceutical
8.2.1 Takeda Pharmaceutical Comapny Information
8.2.2 Takeda Pharmaceutical Business Overview
8.2.3 Takeda Pharmaceutical Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.2.4 Takeda Pharmaceutical Sleeping Pills Product Portfolio
8.2.5 Takeda Pharmaceutical Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.3.4 Sanofi Sleeping Pills Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Hayao
8.4.1 Hayao Comapny Information
8.4.2 Hayao Business Overview
8.4.3 Hayao Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.4.4 Hayao Sleeping Pills Product Portfolio
8.4.5 Hayao Recent Developments
8.5 Cayman Chemical
8.5.1 Cayman Chemical Comapny Information
8.5.2 Cayman Chemical Business Overview
8.5.3 Cayman Chemical Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.5.4 Cayman Chemical Sleeping Pills Product Portfolio
8.5.5 Cayman Chemical Recent Developments
8.6 Aurobindo Pharma
8.6.1 Aurobindo Pharma Comapny Information
8.6.2 Aurobindo Pharma Business Overview
8.6.3 Aurobindo Pharma Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.6.4 Aurobindo Pharma Sleeping Pills Product Portfolio
8.6.5 Aurobindo Pharma Recent Developments
8.7 Apotex
8.7.1 Apotex Comapny Information
8.7.2 Apotex Business Overview
8.7.3 Apotex Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.7.4 Apotex Sleeping Pills Product Portfolio
8.7.5 Apotex Recent Developments
8.8 Ambitropin
8.8.1 Ambitropin Comapny Information
8.8.2 Ambitropin Business Overview
8.8.3 Ambitropin Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.8.4 Ambitropin Sleeping Pills Product Portfolio
8.8.5 Ambitropin Recent Developments
8.9 Allegiant Health
8.9.1 Allegiant Health Comapny Information
8.9.2 Allegiant Health Business Overview
8.9.3 Allegiant Health Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.9.4 Allegiant Health Sleeping Pills Product Portfolio
8.9.5 Allegiant Health Recent Developments
8.10 Actellon Pharmaceuticals
8.10.1 Actellon Pharmaceuticals Comapny Information
8.10.2 Actellon Pharmaceuticals Business Overview
8.10.3 Actellon Pharmaceuticals Sleeping Pills Sales, Value and Gross Margin (2020-2025)
8.10.4 Actellon Pharmaceuticals Sleeping Pills Product Portfolio
8.10.5 Actellon Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Sleeping Pills Value Chain Analysis
9.1.1 Sleeping Pills Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Sleeping Pills Sales Mode & Process
9.2 Sleeping Pills Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Sleeping Pills Distributors
9.2.3 Sleeping Pills Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings